GT Biopharma, Inc. (GTBP)
0.3036
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 15:26
GT Biopharma Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.0056 |
| December 31, 2023 | 0.0078 |
| September 30, 2023 | 0.0092 |
| June 30, 2023 | 0.0102 |
| March 31, 2023 | 0.0113 |
| December 31, 2022 | 0.0148 |
| September 30, 2022 | 0.0124 |
| June 30, 2022 | 0.0144 |
| March 31, 2022 | 0.0139 |
| December 31, 2021 | 0.0014 |
| September 30, 2021 | 0.001 |
| June 30, 2021 | 0.0009 |
| March 31, 2021 | 0.0013 |
| December 31, 2020 | -0.8999 |
| September 30, 2020 | -0.7806 |
| June 30, 2020 | -0.8037 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.6474 |
| December 31, 2019 | -0.6979 |
| September 30, 2019 | -0.7346 |
| June 30, 2019 | 1.350 |
| March 31, 2019 | 1.128 |
| December 31, 2018 | 0.9363 |
| September 30, 2018 | 0.7883 |
| June 30, 2018 | 0.028 |
| March 31, 2018 | 0.0117 |
| December 31, 2017 | 0.0001 |
| September 30, 2017 | 0.0001 |
| June 30, 2017 | -0.6236 |
| March 31, 2017 | -0.6573 |
| December 31, 2016 | -0.6619 |
| September 30, 2016 | -0.6627 |
| June 30, 2016 | -0.6768 |
| March 31, 2016 | -0.5276 |
| December 31, 2015 | -0.1934 |
| September 30, 2015 | -0.2501 |
| June 30, 2015 | -0.1937 |
| March 31, 2015 | -0.0755 |
| December 31, 2014 | -0.1142 |
| September 30, 2014 | -0.2801 |
| June 30, 2014 | -0.4144 |
| March 31, 2014 | -0.4159 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.788M |
| Total Liabilities (Quarterly) | 2.219M |
| Shareholders Equity (Quarterly) | 3.569M |
| Current Ratio | 2.380 |